Abstract
Graft-versus-host disease (GVHD) is the main complication after hematopoietic stem cell transplantation (HSCT). Evidence for non-HLA gene polymorphisms as a cause of GVHD lacks consistency, which is, in part, due to methodological issues of previous candidate gene association studies and small effect size of their results, demanding for larger scale and more robust approaches. Here, non-HLA gene polymorphisms were studied on a large population (922 HSCT pairs) from a homogeneous ethnic background with selection/correction for important clinical confounders. A methodology was applied exploiting the strength of confirmatory typing in an independent study cohort. Targeting an immunogenome of 2,909 genes, an approach of pooled DNA typing of 4,321 microsatellite (MS) markers in two independent screening steps and confirmation of associated markers by further individual genotyping on combined screening cohorts was used to identify genetic susceptibility loci for moderate to severe GVHD (grades 2–4). Ten MS loci (D5S424, D6S0035i, D1S0818i, DXS0151i, D17S0219i, DXS0629i, DXS0324i, D17S0271i, D6S0330i, and D1S1335i) passed the two pooled DNA typing steps and confirmation by individual sample genotyping; two of these (D1S0818i–ELTD1 and D6S0035i–MAPK14) remain associated following application of Bonferroni’s correction and multivariate analysis. The MAPK14 locus was exemplarily explored by typing of haplotype single nucleotide polymorphisms (SNP) confirming this association. This study identified several new MS susceptibility loci for GVHD that warrant further investigation. Immunogenome scanning using MS markers is a useful method for the identification of non-HLA gene loci associating with HSCT outcomes.
Similar content being viewed by others
References
Andre-Schmutz I, Le Deist F, Hacein-Bey-Abina S, Vitetta E, Schindler J, Chedeville G, Vilmer E, Fischer A, Cavazzana-Calvo M (2002) Immune reconstitution without graft-versus-host disease after haemopoietic stem-cell transplantation: a phase 1/2 study. Lancet 360:130–137
Bahram S, Inoko H (2007) Microsatellite markers for genome-wide association studies. Nat Genet(8)
Baron C, Somogyi R, Greller LD, Rineau V, Wilkinson P, Cho CR, Cameron MJ, Kelvin DJ, Chagnon P, Roy DC, Busque L, Sekaly RP, Perreault C (2007) Prediction of graft-versus-host disease in humans by donor gene-expression profiling. PLoS Med 4:e23
Brickner AG (2006) Mechanisms of minor histocompatibility antigen immunogenicity: the role of infinitesimal versus structurally profound polymorphisms. Immunol Res 36:33–41
Cappellano P, Viscoli C, Bruzzi P, Van Lint MT, Pereira CA, Bacigalupo A (2007) Epidemiology and risk factors for bloodstream infections after allogeneic hematopoietic stem cell transplantion. New Microbiol 30:89–99
Chien JW, Zhang XC, Fan W, Wang H, Zhao LP, Martin PJ, Storer BE, Boeckh M, Warren EH, Hansen JA (2012) Evaluation of published single nucleotide polymorphisms associated with acute GVHD. Blood 119:5311–5319
Choi SW, Levine JE, Ferrara JL (2010) Pathogenesis and management of graft-versus-host disease. Immunol Allergy Clin North Am 30:75–101
Colhoun HM, McKeigue PM, Davey Smith G (2003) Problems of reporting genetic associations with complex outcomes. Lancet 361:865–872
Collins HE, Li H, Inda SE, Anderson J, Laiho K, Tuomilehto J, Seldin MF (2000) A simple and accurate method for determination of microsatellite total allele content differences between DNA pools. Hum Genet 106:218–226
Ferrara JL, Levine JE, Reddy P, Holler E (2009) Graft-versus-host disease. Lancet 373:1550–1561
Festen EA, Stokkers PC, van Diemen CC, van Bodegraven AA, Boezen HM, Crusius BJ, Hommes DW, van der Woude CJ, Balschun T, Verspaget HW, Schreiber S, de Jong DJ, Franke A, Dijkstra G, Wijmenga C, Weersma RK (2010) Genetic analysis in a Dutch study sample identifies more ulcerative colitis susceptibility loci and shows their additive role in disease risk. Am J Gastroenterol 105:395–402
Genovese MC, Cohen SB, Wofsy D, Weinblatt ME, Firestein GS, Brahn E, Strand V, Baker DG, Tong SE (2011) A 24-week, randomized, double-blind, placebo-controlled, parallel group study of the efficacy of oral SCIO-469, a p38 mitogen-activated protein kinase inhibitor, in patients with active rheumatoid arthritis. J Rheumatol 38:846–854
Hansen JA, Chien JW, Warren EH, Zhao LP, Martin PJ (2010) Defining genetic risk for graft-versus-host disease and mortality following allogeneic hematopoietic stem cell transplantation. Curr Opin Hematol 17:483–492
Harkensee C, Oka A, Onizuka M, Middleton PG, Inoko H, Hirayasu K, Kashiwase K, Yabe T, Nakaoka H, Gennery AR, Ando K, Morishima Y (2012) Single nucleotide polymorphisms and outcome risk in unrelated mismatched hematopoietic stem cell transplantation: an exploration study. Blood 119:6365–6372
Hill GR, Kuns RD, Raffelt NC, Don AL, Olver SD, Markey KA, Wilson YA, Tocker J, Alexander WS, Clouston AD, Roberts AW, MacDonald KP (2010) SOCS3 regulates graft-versus-host disease. Blood 116:287–296
Horowitz MM, Gale RP, Sondel PM, Goldman JM, Kersey J, Kolb HJ, Rimm AA, Ringden O, Rozman C, Speck B et al (1990) Graft-versus-leukemia reactions after bone marrow transplantation. Blood 75:555–562
Hui J, Oka A, James A, Palmer LJ, Musk AW, Beilby J, Inoko H (2008) A genome-wide association scan for asthma in a general Australian population. Hum Genet 123:297–306
Jorgenson E, Witte JS (2007) Reply: Microsatellite markers for genome-wide association studies. Nat Genet(8)
Kang YJ, Otsuka M, van den Berg A, Hong L, Huang Z, Wu X, Zhang DW, Vallance BA, Tobias PS, Han J (2010) Epithelial p38alpha controls immune cell recruitment in the colonic mucosa. PLoS Pathog 6:e1000934
Kawashima M, Tamiya G, Oka A, Hohjoh H, Juji T, Ebisawa T, Honda Y, Inoko H, Tokunaga K (2006) Genomewide association analysis of human narcolepsy and a new resistance gene. Am J Hum Genet 79:252–263
Kikuchi T, Naruse TK, Onizuka M, Li S, Kimura T, Oka A, Morishima Y, Kulski JK, Ichimiya S, Sato N, Inoko H (2007) Mapping of susceptibility and protective loci for acute GVHD in unrelated HLA-matched bone marrow transplantation donors and recipients using 155 microsatellite markers on chromosome 22. Immunogenetics 59:99–108
Kollman C, Howe CW, Anasetti C, Antin JH, Davies SM, Filipovich AH, Hegland J, Kamani N, Kernan NA, King R, Ratanatharathorn V, Weisdorf D, Confer DL (2001) Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age. Blood 98:2043–2051
Korb A, Tohidast-Akrad M, Cetin E, Axmann R, Smolen J, Schett G (2006) Differential tissue expression and activation of p38 MAPK alpha, beta, gamma, and delta isoforms in rheumatoid arthritis. Arthritis Rheum 54:2745–2756
Lander ES, Schork NJ (1994) Genetic dissection of complex traits. Science 265:2037–2048
Leemans JC, te Velde AA, Florquin S, Bennink RJ, de Bruin K, van Lier RA, van der Poll T, Hamann J (2004) The epidermal growth factor-seven transmembrane (EGF-TM7) receptor CD97 is required for neutrophil migration and host defense. J Immunol 172:1125–1131
Leung DW (2001) The structure and functions of human lysophosphatidic acid acyltransferases. Front Biosci 6:D944–D953
Li S, Kawata H, Katsuyama Y, Ota M, Morishima Y, Mano S, Kulski JK, Naruse T, Inoko H (2004) Association of polymorphic MHC microsatellites with GVHD, survival, and leukemia relapse in unrelated hematopoietic stem cell transplant donor/recipient pairs matched at five HLA loci. Tissue Antigens 63:362–368
Li T, He S (2006) Induction of IL-6 release from human T cells by PAR-1 and PAR-2 agonists. Immunol Cell Biol 84:461–466
Loren AW, Bunin GR, Boudreau C, Champlin RE, Cnaan A, Horowitz MM, Loberiza FR, Porter DL (2006) Impact of donor and recipient sex and parity on outcomes of HLA-identical sibling allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 12:758–769
Morishima Y, Sasazuki T, Inoko H, Juji T, Akaza T, Yamamoto K, Ishikawa Y, Kato S, Sao H, Sakamaki H, Kawa K, Hamajima N, Asano S, Kodera Y (2002) The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically HLA-A, HLA-B, and HLA-DR matched unrelated donors. Blood 99:4200–4206
Morishima Y, Yabe T, Matsuo K, Kashiwase K, Inoko H, Saji H, Yamamoto K, Maruya E, Akatsuka Y, Onizuka M, Sakamaki H, Sao H, Ogawa S, Kato S, Juji T, Sasazuki T, Kodera Y (2007) Effects of HLA allele and killer immunoglobulin-like receptor ligand matching on clinical outcome in leukemia patients undergoing transplantation with T-cell-replete marrow from an unrelated donor. Biol Blood Marrow Transplant 13:315–328
Mullally A, Kim H, Li C, Mohseni M, Ho VT, Alyea EP, Antin JH, Soiffer RJ, Ritz J (2008) Comprehensive typing of 1143 single nucleotide polymorphisms (SNP) in 220 immunoregulatory genes demonstrates that polymorphisms in CCL3, CCL4 and CCL27 modulate the risk of acute graft-versus-host disease (GVHD). Biol Blood Marrow Transplant 14:14
Ogawa S, Matsubara A, Onizuka M, Kashiwase K, Sanada M, Kato M, Nannya Y, Akatsuka Y, Satake M, Takita J, Chiba S, Saji H, Maruya E, Inoko H, Morishima Y, Kodera Y, Takehiko S (2008) Exploration of the genetic basis of GVHD by genetic association studies. Biol Blood Marrow Transplant 15:39–41
Paczesny S, Hanauer D, Sun Y, Reddy P (2009) New perspectives on the biology of acute GVHD. Bone Marrow Transplant 45:1–11
Pallua S, Giesinger J, Oberguggenberger A, Kemmler G, Nachbaur D, Clausen J, Kopp M, Sperner-Unterweger B, Holzner B (2010) Impact of GvHD on quality of life in long-term survivors of haematopoietic transplantation. Bone Marrow Transplant 45:1534–1539
Perez-Simon JA, Diez-Campelo M, Martino R, Brunet S, Urbano A, Caballero MD, de Leon A, Valcarcel D, Carreras E, del Canizo MC, Lopez-Fidalgo J, Sierra J, San Miguel JF (2005) Influence of the intensity of the conditioning regimen on the characteristics of acute and chronic graft-versus-host disease after allogeneic transplantation. Br J Haematol 130:394–403
Randolph SS, Gooley TA, Warren EH, Appelbaum FR, Riddell SR (2004) Female donors contribute to a selective graft-versus-leukemia effect in male recipients of HLA-matched, related hematopoietic stem cell transplants. Blood 103:347–352
Schork NJ (1997) Genetics of complex disease: approaches, problems, and solutions. Am J Respir Crit Care Med 156:S103–S109
Socie G, Loiseau P, Tamouza R, Janin A, Busson M, Gluckman E, Charron D (2001) Both genetic and clinical factors predict the development of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Transplantation 72:699–706
Tamiya G, Shinya M, Imanishi T, Ikuta T, Makino S, Okamoto K, Furugaki K, Matsumoto T, Mano S, Ando S, Nozaki Y, Yukawa W, Nakashige R, Yamaguchi D, Ishibashi H, Yonekura M, Nakami Y, Takayama S, Endo T, Saruwatari T, Yagura M, Yoshikawa Y, Fujimoto K, Oka A, Chiku S, Linsen SE, Giphart MJ, Kulski JK, Fukazawa T, Hashimoto H, Kimura M, Hoshina Y, Suzuki Y, Hotta T, Mochida J, Minezaki T, Komai K, Shiozawa S, Taniguchi A, Yamanaka H, Kamatani N, Gojobori T, Bahram S, Inoko H (2005) Whole genome association study of rheumatoid arthritis using 27,039 microsatellites. Hum Mol Genet 14:2305–2321
Turpeinen H, Volin L, Nikkinen L, Ojala P, Palotie A, Saarela J, Partanen J (2009) Genetic similarity of chromosome 6 between patients receiving hematopoietic stem cell transplantation and HLA matched sibling donors. Haematologica 94:528–535
Uhlmann-Schiffler H, Kiermayer S, Stahl H (2009) The DEAD box protein Ddx42p modulates the function of ASPP2, a stimulator of apoptosis. Oncogene 28:2065–2073
Waetzig GH, Seegert D, Rosenstiel P, Nikolaus S, Schreiber S (2002) p38 mitogen-activated protein kinase is activated and linked to TNF-alpha signaling in inflammatory bowel disease. J Immunol 168:5342–5351
Weisdorf D, Spellman S, Haagenson M, Horowitz M, Lee S, Anasetti C, Setterholm M, Drexler R, Maiers M, King R, Confer D, Klein J (2008) Classification of HLA-matching for retrospective analysis of unrelated donor transplantation: revised definitions to predict survival. Biol Blood Marrow Transplant 14:748–758
Yano K, Kanie T, Okamoto S, Kojima H, Yoshida T, Maruta I, Dohi H, Morishita Y, Ozawa K, Sao H, Sakamaki H, Hiraoka S, Imoto S, Morishima Y, Kodera Y (2000) Quality of life in adult patients after stem cell transplantation. Int J Hematol 71:283–289
Yona S, Stacey M (2010) Adhesion-GPCRs: structure to function. Preface. Adv Exp Med Biol 706:5–7
Zhernakova A, van Diemen CC, Wijmenga C (2009) Detecting shared pathogenesis from the shared genetics of immune-related diseases. Nat Rev Genet 10:43–55
Acknowledgments
The authors are greatly indebted to the staff members of the transplantation centers, donor centers, and the JMDP office for their generous cooperation. This work was supported by the Research on Allergic Disease and Immunology (Health and Labor Science Research Grant H20-014, H23-010) from the Ministry of Health, Labor, and Welfare of Japan, and a grant (3224–22133011) from the Ministry of Education, Culture, Sports, Science and Technology, Japan, through JMDP. The authors want to express their gratitude to the Daiwa Foundation, which contributed to the cost of custom MS marker design with a small grant. CH was supported during this research by a fellowship from the Kay Kendall Leukaemia Fund UK (KKLF) (grant nos. 291 and 297). We thank laboratory staff at the Division of Molecular Life Sciences at Tokai University for their kind support: Mr. Hayashi for technical advice, and Ms. Yamaguchi, Ms. Matsushita, and Ms. Higuchi for supporting the genotyping work.
Author information
Authors and Affiliations
Consortia
Corresponding author
Rights and permissions
About this article
Cite this article
Harkensee, C., Oka, A., Onizuka, M. et al. Microsatellite scanning of the immunogenome associates MAPK14 and ELTD1 with graft-versus-host disease in hematopoietic stem cell transplantation. Immunogenetics 65, 417–427 (2013). https://doi.org/10.1007/s00251-013-0691-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00251-013-0691-z